5-Aminosalicylic Acid (Standard)
Based on 1 Customer Validation
5-Aminosalicylic Acid (Standard) is the analytical standard of 5-Aminosalicylic Acid. This product is intended for research and analytical applications. 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN).
For research use only. We do not sell to patients.
- Purity: 99.54%
- CAS No.: 89-57-6
- Formula: C₇H₇NO₃
- Molecular Weight:153.14
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Purity & Documentation
-
Help & FAQs
-
HY-15027
5-Aminosalicylic Acid
-
HY-10582
Flurbiprofen
-
HY-N0551
Wedelolactone
-
HY-10582R
Flurbiprofen (Standard)
-
HY-17386
Rosiglitazone
-
HY-18570
1-Naphthaleneacetic acid
-
HY-18570B
1-Naphthaleneacetic acid,suitable for plant cell culture
-
HY-15930
TMB
-
HY-10519
BMS-345541
-
HY-15902
ABTS diammonium salt
-
HY-10074
TPCA-1
-
HY-10257
BAY 11-7085
Product Information
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 89-57-6
-
Appearance Solid
-
Molecular Weight 153.14
-
Formula C₇H₇NO₃
-
Color Off-white to light yellow
-
SMILES
OC1=C(C(O)=O)C=C(N)C=C1
-
Synonyms
Mesalamine (Standard); 5-ASA (Standard); Mesalazine (Standard)
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Dammann K, et al. PAK1 modulates a PPARγ/NF-κB cascade in intestinal inflammation. Biochim Biophys Acta. 2015 Oct;1853(10 Pt A):2349-60. [Content Brief]
[2]. Rousseaux C, et al. The 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ. Carcinogenesis. 2013 Nov;34(11):2580-6. [Content Brief]
[3]. Fang HM, et al. 5-aminosalicylic acid in combination with Nimesulide inhibits proliferation of colon carcinoma cells in vitro. World J Gastroenterol. 2007 May 28;13(20):2872-7. [Content Brief]
[4]. Ramadan A, et al. Mesalazine, an osteopontin inhibitor: The potential prophylactic and remedial roles in induced liver fibrosis in rats. Chem Biol Interact. 2018 Jun 1;289:109-118. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
5-Aminosalicylic Acid (Standard) Related Classifications
HY-15027R Related Classifications
Powered by Bioz